• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱移行细胞癌患者接受根治性膀胱切除术后鳞状分化的作用。

The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

作者信息

Antunes Alberto A, Nesrallah Luciano J, Dall'Oglio Marcos F, Maluf Carlos E, Camara Cesar, Leite Katia R, Srougi Miguel

机构信息

Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil and Hospital Sìrio Libanes, Sao Paulo, Brazil.

出版信息

Int Braz J Urol. 2007 May-Jun;33(3):339-45; discussion 346. doi: 10.1590/s1677-55382007000300006.

DOI:10.1590/s1677-55382007000300006
PMID:17626650
Abstract

OBJECTIVE

We aim at determining the prognostic value of squamous differentiation in patients with transitional cell carcinoma (TCC) of the bladder that were treated with radical cystectomy.

MATERIALS AND METHODS

From January 1993 to January 2005, we retrospectively selected 113 patients. Correlations among squamous differentiation with other clinical and pathological features were assessed by both chi-square and Fisher tests. The Kaplan-Meier method was used to evaluate survival curves and statistical significance was determined by the log-rank test. Multivariate analysis was performed through a Cox proportional hazards regression model.

RESULTS

Squamous differentiation was observed in 25 (22.1%) of the 113 patients. This finding was significantly related only to the pathological stage. Mean follow-up after cystectomy was 31.7 +/- 28.5 months. Disease recurrence occurred in 16 (64%) and 30 (34%) patients with and without squamous differentiation (log-rank test, p = 0.001), and mortality occurred in 10 (40%) and 14 (16%) of the patients with and without squamous differentiation respectively. Univariate analysis revealed that pathological stage, squamous differentiation, tumor size and lymph node involvement were significant predictors of cancer-specific survival. However, only squamous differentiation and tumor size were independent prognostic variables on multivariate analysis.

CONCLUSIONS

Squamous differentiation was an independent prognostic factor for cancer specific survival in patients with bladder cancer treated with radical cystectomy. Further studies with a larger number of patients are necessary to confirm these results.

摘要

目的

我们旨在确定接受根治性膀胱切除术治疗的膀胱移行细胞癌(TCC)患者中鳞状分化的预后价值。

材料与方法

从1993年1月至2005年1月,我们回顾性选取了113例患者。通过卡方检验和费舍尔检验评估鳞状分化与其他临床及病理特征之间的相关性。采用Kaplan-Meier法评估生存曲线,并通过对数秩检验确定统计学意义。通过Cox比例风险回归模型进行多变量分析。

结果

113例患者中有25例(22.1%)观察到鳞状分化。这一发现仅与病理分期显著相关。膀胱切除术后的平均随访时间为31.7±28.5个月。有和无鳞状分化的患者中分别有16例(6�%)和30例(34%)出现疾病复发(对数秩检验,p = 0.001),有和无鳞状分化的患者中分别有10例(40%)和14例(16%)死亡。单变量分析显示,病理分期、鳞状分化、肿瘤大小和淋巴结受累是癌症特异性生存的显著预测因素。然而,多变量分析显示只有鳞状分化和肿瘤大小是独立的预后变量。

结论

鳞状分化是接受根治性膀胱切除术治疗的膀胱癌患者癌症特异性生存的独立预后因素。需要更多患者的进一步研究来证实这些结果。

相似文献

1
The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.膀胱移行细胞癌患者接受根治性膀胱切除术后鳞状分化的作用。
Int Braz J Urol. 2007 May-Jun;33(3):339-45; discussion 346. doi: 10.1590/s1677-55382007000300006.
2
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.膀胱尿路上皮癌在膀胱切除标本中出现鳞状和腺性分化是否预示预后不良?一项深入的病例对照分析。
Urol Oncol. 2014 Feb;32(2):117-27. doi: 10.1016/j.urolonc.2012.08.017. Epub 2013 Mar 7.
3
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.根治性膀胱切除术治疗的纯鳞状细胞癌和具有鳞状分化的尿路上皮癌患者的比较结果。
J Urol. 2012 Jan;187(1):74-9. doi: 10.1016/j.juro.2011.09.056. Epub 2011 Nov 16.
4
The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.病理因素在预测接受根治性膀胱切除术治疗的膀胱和前列腺移行细胞癌患者癌症特异性生存率中的价值。
Cancer. 1993 Jun 15;71(12):3993-4001. doi: 10.1002/1097-0142(19930615)71:12<3993::aid-cncr2820711233>3.0.co;2-y.
5
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
6
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.鳞状和腺体分化对膀胱癌根治性膀胱切除术后生存的影响。
J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.
7
Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.根治性膀胱切除术后埃及大单一中心队列中不同组织病理学类型膀胱癌的病理特征和预后指标。
World J Urol. 2018 Nov;36(11):1835-1843. doi: 10.1007/s00345-018-2331-6. Epub 2018 May 14.
8
Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.浅表性膀胱尿路上皮癌患者的鳞状分化与高复发风险和低生存率相关。
BMC Cancer. 2017 Aug 8;17(1):530. doi: 10.1186/s12885-017-3520-1.
9
Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.初始活检或膀胱肿瘤经尿道切除术在检测根治性膀胱切除术中组织学变异方面的敏感性。
BMC Urol. 2015 May 30;15:46. doi: 10.1186/s12894-015-0037-2.
10
Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.膀胱尿路上皮癌中鳞状分化的临床意义
Cancer Control. 2018 Jan-Dec;25(1):1073274818800269. doi: 10.1177/1073274818800269.

引用本文的文献

1
Knockdown of Keratin 6 Within Arsenite-Transformed Human Urothelial Cells Decreases Basal/Squamous Expression, Inhibits Growth, and Increases Cisplatin Sensitivity.砷转化人尿路上皮细胞中角蛋白 6 的敲低降低了基底/鳞状表达,抑制了生长,并增加了顺铂敏感性。
Cells. 2024 Oct 31;13(21):1803. doi: 10.3390/cells13211803.
2
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.多参数 MRI 对具有异型组织学的膀胱尿路上皮癌的影像学综述:要点和陷阱。
Abdom Radiol (NY). 2024 Aug;49(8):2797-2811. doi: 10.1007/s00261-024-04397-3. Epub 2024 Jun 7.
3
The Impact of Variant Histology in Patients with Urothelial Carcinoma Treated with Radical Cystectomy: Can We Predict the Presence of Variant Histology?
根治性膀胱切除术治疗尿路上皮癌患者中变异组织学的影响:我们能否预测变异组织学的存在?
Curr Oncol. 2023 Sep 27;30(10):8841-8852. doi: 10.3390/curroncol30100638.
4
Clinical features of patients with -deleted bladder cancer.伴有特定缺失的膀胱癌患者的临床特征
Am J Cancer Res. 2023 Jan 15;13(1):326-339. eCollection 2023.
5
Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma.鳞状或腺体分化预示着 pT1 尿路上皮癌预后不良。
In Vivo. 2022 Sep-Oct;36(5):2365-2370. doi: 10.21873/invivo.12968.
6
Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes.尿路上皮癌组织学变体概述:当前趋势及治疗结果的叙述性综述
Transl Androl Urol. 2022 Jun;11(6):877-901. doi: 10.21037/tau-22-43.
7
Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma.高级别膀胱癌和尿路上皮癌特殊变异型中上皮-间质转化标志物的检测。
Asian Pac J Cancer Prev. 2022 Jun 1;23(6):2079-2087. doi: 10.31557/APJCP.2022.23.6.2079.
8
Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer-narrative review.组织学和分子数据相结合以改善非肌层浸润性膀胱癌的预后预测——叙述性综述
Transl Cancer Res. 2020 Nov;9(11):7323-7336. doi: 10.21037/tcr-20-2257.
9
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.晚期尿路上皮癌的组织学亚型与 PD-1/PD-L1 阻断治疗反应:一项回顾性研究。
J Urol. 2020 Jul;204(1):63-70. doi: 10.1097/JU.0000000000000761. Epub 2020 Jan 23.
10
Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma.鳞状分化对上尿路尿路上皮癌患者膀胱内复发及预后的影响。
Ann Transl Med. 2019 Aug;7(16):377. doi: 10.21037/atm.2019.07.31.